Brainsway Stock Analysis

BrainsWay Pink Sheet Analysis Notes

About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. BrainsWay recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 23rd of May 2011. Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 118 people.The quote for BrainsWay is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BrainsWay please contact Christopher Jako at 972 2 582 4030 or go to https://www.brainsway.com.

BrainsWay Investment Alerts

BrainsWay Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BrainsWay's market, we take the total number of its shares issued and multiply it by BrainsWay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

BrainsWay Profitablity

The company has Profit Margin (PM) of (0.37) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.29) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.29.

Technical Drivers

As of the 30th of November, BrainsWay shows the mean deviation of 1.49, and Risk Adjusted Performance of 0.1029. BrainsWay technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BrainsWay risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if BrainsWay is priced correctly, providing market reflects its regular price of 3.15 per share. Given that BrainsWay has variance of 37.88, we suggest you to validate BrainsWay's prevailing market performance to make sure the company can sustain itself at a future point.

BrainsWay Price Movement Analysis

BrainsWay Predictive Daily Indicators

BrainsWay Forecast Models

BrainsWay's time-series forecasting models are one of many BrainsWay's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BrainsWay's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how BrainsWay prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BrainsWay shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as BrainsWay. By using and applying BrainsWay Pink Sheet analysis, traders can create a robust methodology for identifying BrainsWay entry and exit points for their positions.

When running BrainsWay's price analysis, check to measure BrainsWay's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrainsWay is operating at the current time. Most of BrainsWay's value examination focuses on studying past and present price action to predict the probability of BrainsWay's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrainsWay's price. Additionally, you may evaluate how the addition of BrainsWay to your portfolios can decrease your overall portfolio volatility.